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Background: Information about antibiotic prescribing practice in primary care is not available for Ireland, unlike
other European countries. The study aimed to ascertain the types of antibiotics and the corresponding conditions
seen in primary care and whether general practitioners (GPs) felt that an antibiotic was necessary at the time of
consultation. This information will be vital to inform future initiatives in prudent antibiotic prescribing in primary
care.
Methods: Participating GPs gathered data on all antibiotics prescribed by them in 100 consecutive patients’
consultations as well as data on the conditions being treated and whether they felt the antibiotic was necessary.
Results: 171 GPs collected data on 16,899 consultations. An antibiotic was prescribed at 20.16% of these
consultations. The majority were prescribed for symptoms or diagnoses associated with the respiratory system; the
highest rate of prescribing in these consultations were for patients aged 15–64 years (62.23%). There is a high rate
of 2nd and 3rd line agents being used for common ailments such as otitis media and tonsillitis. Amoxicillin, which is
recommended as 1st line in most common infections, was twice as likely to be prescribed if the prescription was
for deferred used or deemed unnecessary by the GP.
Conclusion: The study demonstrates that potentially inappropriate prescribing is occurring in the adult population
and the high rate of broad-spectrum antimicrobial agents is a major concern. This study also indicates that
amoxicillin may be being used for its placebo effect rather than specifically for treatment of a definite bacterial
infection.Background
Antibiotic resistance is a major concern globally. Anti-
biotic consumption increases the likelihood for an indi-
vidual to develop bacterial resistance [1]. The majority
of antibiotic prescribing takes place in primary care and
general practitioners (GPs) have been encouraged to
prescribe antibiotics more rationally and to only give
antibiotics when necessary [2].
Wide variation in antibiotic prescribing practices has
been shown to exist in Europe demonstrating more than
a threefold difference in antibiotic prescribing rates
between countries, without any logical reasoning to
explain the variation [3].* Correspondence: stephen.byrne@ucc.ie
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reproduction in any medium, provided the orIn the Republic of Ireland (ROI), there has been in-
creasing levels of resistance and antibiotic use [4]. Quin-
olone resistance rates in E.coli increased from 5% in
2002 to 23% in 2008. Although ROI has seen small
reductions in antibiotic use since 2009, high seasonal
variation is still apparent which, in other countries, is
also associated with high antibiotic consumption
(France, Greece, Portugal and Italy) [3]. The reductions
in antibiotic use seen in ROI have been associated with
the stabilisation of rates of penicillin non-susceptible
Streptococcus Pneumoniae (PNSP). The proportion of
PNSP increased in ROI from 10.3% in 2004 to 23.1% in
2008 and decreased in 2010 to 18.2% [5]. The reductions
in antibiotic use in ROI is low in comparison to that of
Belgium and France where sustained campaigns have
been associated with reductions of 36% and 26.5%
respectively [6,7].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Symptoms and diagnoses associated with the
respiratory system
Clinical Entity Symptoms Diagnosis
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shown to influence prescribing even in the absence of a
clinical indication for an antibiotic [8,9]. The majority of
ROI citizens must pay a fee to visit their GP and this has
shown as a possible influence on the GP’s decision to
prescribe an antibiotic during the consultation [10].
The purpose of this study was to describe specific
diagnoses for which systemic antibiotics are prescribed
in primary care by GPs in the ROI, to assess adherence
to recent national guidelines and gain more information
on antibiotics that are prescribed unnecessarily.
Methods
Study population
The majority of GPs in ROI (> 80%) are regular atten-
dees of the small group continuing medical education
(CME) network which is run by the Irish College of
General Practitioners (ICGP). The CME network is pro-
vided in a format whereby GPs meet on a regular basis
to learn in a mutually supportive group. The system is
resourced by 37 CME tutors nationally with a target
population of 1,934 GPs and an attendance of over 80%
of all GPs in Ireland [11] Tutors run monthly meetings
each year from September to May.
All CME tutors nationally and their CME groups were
invited to participate in the study from October 2008 to
April 2010. Each GP also completed an anonymous
demographic questionnaire detailing their practice size,
area, years in practice and post-graduate experience. All
participating GPs were both state and privately funded.
The state issues General Medical Service (GMS) cards to
patients that are deemed unable to pay for medical care.
Eligibility for GMS cards is dependent on a number of
factors including income, marital status and age. In
2009, 33% of the population in Ireland were GMS card
holders [12]. All other patients (private patients) must
pay for their medical care.
Procedure
Participating GPs gathered data on 100 consecutive con-
sultations using a predefined piloted data collection pro-
forma (Additional file 1). Out of hours consultations
were not recorded. No data was collected during the
summer months. Anonymised patient information was
recorded including the age, gender and patient payment
status. GPs recorded the reason for the consultation, or
the diagnosis (if a diagnosis was reached). These were
classified by the associated body system e.g. respiratory,
skin, urinary tract disorders. All consultations associated
with the respiratory system were further categorised into
clinical entities and classified as symptoms (e.g. sore ear)
or as diagnoses (e.g. otitis media). These categories are
listed in Table 1. When an antibiotic was prescribed dur-
ing the consultation, details of the prescription anddirections for use were recorded on the data collection
proforma provided. GPs were also asked to record if
they felt the antibiotic was necessary, not necessary or
unsure. It was also recorded if the patient had received
an antibiotic for the same condition in the previous two
weeks. Each antibiotic prescribed and the reason for the
consultation was compared to locally approved guide-
lines on community prescribing of antibiotics in Ireland
[13]. These guidelines contain up-to-date evidence on
the use of antibiotics for common conditions that
present in primary care e.g. tonsillitis, otitis media.
There were four types of deviations detected based on:
(1) choice of antibiotic; (2) duration/frequency of anti-
biotic; (3) dosage of antibiotic; (4) diagnosis. Deviations
due to diagnosis were recorded when antibiotics were
prescribed for conditions not included in the guidelines,
due to the lack of evidence to support their use
(e.g. sore throat, cough). GPs were encouraged to provide
additional information regarding the antibiotic prescrip-
tion particularly if it was an influence on their decision
(e.g. pregnancy, sensitivity analysis) and this was taken
into account when deviations were assessed.National antibiotic consumption data
Data regarding antibiotic consumption in ROI during
the time of the study (October 2008-April 2010) was
provided by the Health Protection Surveillance Centre
(HPSC). This data is from IMS Health, a pharmaceutical
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saler to retail pharmacy sales data from over 95% of the
wholesalers and manufacturers in Ireland. Antibiotic
consumption was measured in Defined Daily Dose
(DDD) which is the assumed average maintenance dose
per day for a drug used for its main indication in adults.Analysis
Data was analysed using Microsoft Office ExcelW (2007)
and Predictive Analytics SoftWare (PASWW, Chicago,
Illinois, USA) version 17.0. A sample (10%) was double-
checked for coding entry errors. Data collected was tested
for normality and parametric/non-parametric tests were
used as appropriate. The Pearson’s chi-squared tests were
performed to compare categorical variables. Odds ratios
(ORs) with corresponding 95% confidence intervals (CIs)
were calculated using logistic regression.
HPSC data was used to compare the pattern of anti-
biotic usage between the national picture and the study
GP population.Ethical approval and Informed Consent
The study was approved by the Clinical Research Ethics
Committee of the Cork Teaching Hospitals. Informed
consent was obtained from all GPs by participation in the
study.Results
Data were collected from 171 GPs nationally who recorded
information on 16,899 consultations. The mean (±SD)
number of consultations recorded per GP was 98.82±5.37.
The majority of GPs who participated completed a demo-
graphics questionnaire (84.80%, 145). All GPs were from
combined GMS and private practices and situated in vari-
ous settings: urban (37.24%, 54), rural (24.83%, 36) and
mixed (37.93%, 55)
The majority of attendees were females (58.80%, 9,936)
and held a GMS card (53.83%, 9,096).
An antibiotic was prescribed in one-fifth of consulta-
tions recorded (20.16%, 3,407). A quarter of these (25.74%,
877) were prescribed to a child between the ages of 1 and
14 years. A small proportion had received an antibiotic for
the same presenting complaint in the previous two weeks
prior to the consultation (8.22%, 280).Choice of antibiotic
Co-amoxiclav, amoxicillin and clarithromycin were the
most commonly prescribed antibiotics and this was also
reflected in the national data (Table 2). With the excep-
tion of doxycycline and lymecycline, the pattern of anti-
biotic usage in terms of ranking was very similar.Reasons for an antibiotic prescription
Symptoms/diagnoses associated with the respiratory
system accounted for the majority of antibiotic prescrip-
tions (64.72%, 2,205), followed by skin (10.21%, 348) and
urinary tract disorders (8.63%, 294). Overall, 22.63% of
consultations (3,824) recorded either a diagnosis or
symptoms of the respiratory system. The majority of
these consultations received an antibiotic prescription
(57.66%, 2,205). Children aged 4–14 years had the high-
est consultation rate where a respiratory symptom/diag-
nosis was recorded (33.94%, 1,298). Patients under the
age of 65 were twice as likely to consult with respiratory
symptoms/diagnoses than younger patients (OR 2.08,
95% CI 1.87-2.23).
Children aged from 0–14 years had the lowest percentage
rate of antibiotic prescribing when presenting with respira-
tory symptoms (52.25%, 767). The highest percentage was
seen for patients aged 15–64 (62.23%, 1,104) (Figure 1). In
consultations with a respiratory diagnosis, 66.08% (1,420)
resulted in an antibiotic prescription, in comparison with
48.22% (787) of those with respiratory symptoms. High pre-
scribing rates (>85%) were seen in patients with throat, ear
and sinus infections recorded. There was also considerable
antibiotic prescribing for conditions not included in the
guidelines such as upper respiratory tract infection (URTI)
(33.10%, 187), cough (35.82%, 173) and sore throat (53.11%,
128) (Figure 2).
Adherence to guidelines
The majority of antibiotic prescriptions were not strictly
in accordance to guidelines (78.05%, 2,659). Nearly half
of the deviations were related to the diagnosis/reason
given for the consultation (46.71%, 1,242). This corre-
lated with the high use of antibiotics for respiratory
symptoms which are not included in the guidelines. The
choice of the antibiotic was also a recurrent deviation
(30.27%, 805). These included deviations such as the use
of 2nd and 3rd line agents for infections as opposed to
the 1st line choice. Antibiotic prescriptions for common
respiratory infections seen in the community corre-
sponded with the recommended first-line choice in less
than 50% of all prescriptions (Table 3). Co-amoxiclav
accounted for almost a quarter of the prescriptions in
tonsillitis (25.09%, 74), otitis media (25.46%, 84), bron-
chitis (27.75%, 187), sinusitis (23.71%, 46) and urinary
tract infections (21.82%, 48).
The majority of antibiotic prescriptions were for im-
mediate use (84.00%, 2,862); co-amoxiclav (23.72%,
679), amoxicillin (18.20%, 521) and clarithromycin
(9.54%, 273) were the most common antibiotics pre-
scribed. There were 470 (13.80%) antibiotic prescrip-
tions for deferred use (2.05% (70) were not recorded).
The majority of these prescriptions were amoxicillin
(39.57%, 186), followed by co-amoxiclav (19.57%, 92)
Table 2 Comparison of the most common antibiotics consumed nationally in primary care and the most common
antibiotics prescribed by General Practitioners in the study. (DDD: defined daily dose; HPSC: Health Protection
Surveillance Centre)
Antibiotic National consumption data (HPSC) GP Study
Rank DDD % Rank Reported prescriptions %
Co-amoxiclav 1 765,235 27.01 1 792 23.66
Amoxicillin 2 448,362 15.83 2 719 21.48
Clarithromycin 3 386,060 13.63 3 308 9.20
Doxycycline 4 176,445 6.23 9 81 2.42
Flucloxacillin 5 128,998 4.55 5 231 6.90
Phenoxymethylpenicillin 6 113,971 4.02 4 233 6.96
Cefaclor 7 108,434 3.83 6 173 5.17
Trimethoprim 8 107,384 3.79 7 131 3.91
Lymecycline 9 97,918 3.46 19 20 0.60
Erythromycin 10 89,771 3.17 8 82 2.45
Ciprofloxacin 12 84,981 3.00 10 78 2.33
Other antibacterials 325,666 11.49 500 14.93
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ferred prescription was issued, it was twice as likely to
be for amoxicillin as any other antibiotic (OR 2.18, 95%
CI 1.78-2.66).
Necessary antibiotics
Most of the antibiotics that were prescribed were deemed
to be necessary for the condition they were beingFigure 1 The number of consultations involving respiratory symptom
prescribed.prescribed for (71.76%, 2,445) and almost a quarter of
these prescriptions were for co-amoxiclav (24.09%, 589).
There were 315 (9.25%) prescriptions that were thought
not to be necessary and prescribers were unsure of 602
(17.67%) prescriptions; amoxicillin was the most common
antibiotic choice in these instances (36.19%, 114 and
29.73%, 179 respectively) (Figure 3). Amoxicillin was twice
as likely to be prescribed when the antibiotic was thoughts/diagnoses by age group and the percentage of antibiotics
Figure 2 Common respiratory conditions and the percentage of antibiotic prescribing for each condition.
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the most common reason for an unnecessary prescription
(17.46%, 55) followed by cough (12.06%, 38) and flu-like
symptoms (9.52%, 30).
Discussion
Overall, this study has identified the huge burden of re-
spiratory symptoms/conditions in general practice inTable 3 Percentages of first-line, second-line and remaining a
Guidelines
Tonsillitis (n = 295) P
Otitis media (n = 330) A
Sinusitis (n = 194) A
D
Bronchitis/Cough (n = 674) A
D
Community acquired pneumonia (n = 25) A
C
D
Urinary Tract infection(uncomplicated female) (n = 220) T
N
*Clarithromycin/Erythromycin is first line in penicillin allergy.Ireland. Nearly a quarter of all the consultations recorded
were due to respiratory illnesses (22.63%). This is higher
than the UK where only approximately 15% of GP consul-
tations are due to these ailments [14]. As with other coun-
tries, the most common cause for an antibiotic prescription
is due to symptoms or conditions relating to the respiratory
system. Overall, children (1–14 years) received the highest
proportion of the antibiotic prescriptions and this isntibiotics according to Irish national guidelines
First line (%) Second line/remaining (%)
































Figure 3 The percentage of the most common antibiotics prescribed that were deemed necessary (n = 2,445), not necessary (n = 315)
and unsure (n = 602) for the presenting patient.
Murphy et al. BMC Family Practice 2012, 13:43 Page 6 of 8
http://www.biomedcentral.com/1471-2296/13/43probably due to the high number of consultations involving
the respiratory system in this age group. Surprisingly,
patients (15–64 years) presenting to the GP have the high-
est rate of antibiotic use per respiratory consultation, with
over 60% of these consultations receiving an antibiotic pre-
scription. Other studies have also shown that children visit
their GP more often with respiratory conditions but in pro-
portion do not receive more antibiotics than adults [14,15].
Research has also shown that antibiotics are not justified to
reduce the risk of serious complications of these conditions
but may be warranted for those over the age of 65 where
the number needed to treat to prevent pneumonia post
chest infection is much lower than younger age groups
(39 vs 119) [16]. Therefore it would be expected to see
higher rates of antibiotic use in the elderly cohort. Possible
explanations for the higher rates of antibiotic use seen in
younger patients (15–64 years) may be due to structure of
the health care system in ROI. The elderly, the very young
(<5 years) and the most socio-economically disadvantaged
are more likely to be GMS card holders due the eligibility
criteria. The average cost for a GP consultation for a private
patient in ROI is €51 [17]. GPs have been shown to over-
estimate the patient’s expectation for a prescription and this
influences the decision to prescribe [18]. This may be more
evident in ROI as GPs may be more sensitive to patients’
expectations if the patient is paying for the consultation[10]. It may be particularly difficult for the GP not to
give a prescription under these circumstances; they may
provide a prescription to reduce the need for re-
consultation if required. Diagnostic uncertainty and fear of
negligence have also been quoted as drivers of antibiotic
overprescribing [19].
There is considerable variation in antibiotic prescribing
between the respiratory clinical entities with a substantial
proportion of prescribing occurring for respiratory symp-
toms. GPs may have had an inclination to label symp-
toms as a diagnosis to gain endorsement of their
prescribing; diagnostic labelling has been shown to be
associated with high levels of antibiotic prescribing [20].
Antibiotics are not recommended for symptoms such
as cough, sore throat but a high level of prescribing was
recorded in these conditions. This is the reason why the
majority of deviations from guidelines in this study were
due to the diagnosis/reason for consultation. A study in
Canada showed that 5% of URTI consultations received
an antibiotic; this is in contrast to 33.10% in this study
[21]. The majority of consultations that diagnosed an ear
infection received an antibiotic (89.49%); USA and the UK
have similar rates while the Netherlands has much lower
rates of 56% [22,23]. In a recent study in the USA, 30% of
children diagnosed with a viral respiratory infection were
prescribed an antibiotic [24].
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to guidelines is low. However, these guidelines have been
recently developed and should be disseminated widely to
have any impact. In the Netherlands, about three-quarters
of antibiotics prescribed are first-line choice [25]. A third of
patients who had been prescribed an antibiotic in the previ-
ous two weeks (i.e. for the same illness) had been prescribed
co-amoxiclav which is recommended as second-line
(broad-spectrum antibiotic); this could suggest that these
cases were not treatment failures but rather viral illnesses.
The majority of tonsillitis presentations are not being
treated with narrow-spectrum antibiotics as considered ap-
propriate. This has a major impact on increasing resistance.
The usage of amoxicillin for otitis media (first line) is
lower than expected at 42.42%, other countries in Europe
have rates of 82% with co-amoxiclav only used in 7% of
cases [23]. Studies have described how a reduction in anti-
biotic usage carries a parallel decrease in resistance
[26,27]. The high incidence of co-amoxiclav has been
shown in other studies in ROI, with the consumption in-
creasing by 80% from 2000–2005 while the use of amoxi-
cillin decreased by 9% in the same time period [28,29]. In
the absence of guidance from public health bodies, it
could be argued that third-party representatives from the
pharmaceutical industry may have contributed to the high
usage of second line and third line agents [30].
In contrast to the high rates of co-amoxiclav, amoxicillin
was more likely to be prescribed than other antibiotics
when the prescription was for deferred/delayed use and
also when the GP did not think that the antibiotic was ne-
cessary for the condition being treated. It could be argued
that this study provides possible evidence that GPs pre-
scribe antibiotics such as amoxicillin as ‘impure placebos’
or ‘pseudoplacebos’, these agents consist of biologically
active agents that have specific efficacy for some condi-
tions but used as a placebo for another condition i.e. anti-
biotics for probable viral infections such as URTI and
cough. A survey in Denmark found that 70% of GPs had
prescribed antibiotics as a placebo intervention in the pre-
vious year [31]. The most common reason quoted for this
was to ‘follow the wish of the patient and avoid conflict’ [31].
Prescribers also report generally positive attitudes about the
useofmedicationtopromotetheplaceboeffect [32].
This study clearly indicates that guidelines need to
be disseminated at a local level with a focus to reduce
antibiotic prescribing for minor respiratory conditions
and reduce broad-spectrum antibiotic prescribing
whenever necessary. Prescribing a course of antibiotics
increases the patient’s risk of developing bacterial resist-
ance for up to a year [1]; GPs should be mindful of this
issue when prescribing antibiotics that are not neces-
sary. It is particularly important to increase public
awareness regarding appropriate antibiotic use to ease
patient pressure on GPs to prescribe.Strengths and weaknesses
The data from this study is valuable as it is the first time
diagnoses are linked to antibiotic consumption in ROI and
also details prescribing behaviour for both private and
GMS card holders. In ROI, private patients are not
required to register with their GP and are therefore free to
visit any GP they wish; patients do not have a unique iden-
tifier. Therefore, it is currently not possible for routine data
collection to take place from electronic sources in ROI.
The reason for the consultation was recorded in free
text words to include all types of reasons provided for an
antibiotic prescription. Other studies have quoted that a
large proportion of primary care visits are difficult to label
with a precise code and also require GPs to participate in
training in coding [14]. Therefore in this study, we were
unable to differentiate between multiple consultations per-
taining to the same episode. However, the number of pre-
vious antibiotics for the same episode was low.
The population of GPs in this study may be skewed to-
wards those with an interest in the area of antibiotic pre-
scribing as their participation was not mandatory as part
of their CME group. However, the national data from the
time of study reflects similar usage patterns of antibiotics.
A possible explanation for the notable higher usage of
doxycycline and lymecycline in the national dataset could
be explained by dermatologists prescribing these agents in
the outpatient setting.
Conclusion
This study provides evidence that antibiotics are probably
not being used as prudently in the community in ROI as
they may be other countries. Children present to their GP
with respiratory symptoms more often than adults, but
higher rates of antibiotic prescribing occur in adults with
similar symptoms. This study also shows that amoxicillin
may be being used for its placebo effect rather than as spe-
cific treatment for bacterial infection.
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